tolmetin has been researched along with omeprazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Morgan, DE; Mutnick, AH; Peroutka, JA; Ross, MB; Sloan, NE | 1 |
1 review(s) available for tolmetin and omeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for tolmetin and omeprazole
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Influencing prescribing practices and associated outcomes utilizing the drug use evaluation process.
Topics: Anti-Bacterial Agents; Drug Monitoring; Drug Utilization; Drug Utilization Review; Forms and Records Control; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Iowa; Joint Commission on Accreditation of Healthcare Organizations; Models, Organizational; Omeprazole; Ondansetron; Outcome Assessment, Health Care; Pharmacy and Therapeutics Committee; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Research Design; Tolmetin | 1994 |